Advertisement
help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 12, No. suppl_1, 11-21, May 2007; doi:10.1634/theoncologist.12-S1-11
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jean-Pierre, P.
Right arrow Articles by Morrow, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jean-Pierre, P.
Right arrow Articles by Morrow, G. R.

Assessment of Cancer-Related Fatigue: Implications for Clinical Diagnosis and Treatment

Pascal Jean-Pierrea,b, Colmar D. Figueroa-Moseleya,c, Sadhna Kohlia,c, Kevin Fiscellab,d, Oxana G. Palesha, Gary R. Morrowa,e

aDepartment of Radiation Oncology, bDepartment of Family Medicine, cDepartment of Medicine, dDepartment of Community and Preventive Medicine, and eDepartment of Psychiatry, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Center, Rochester, New York, USA

Key Words. Cancer • Fatigue • Assessment • Measurement • Instruments

Correspondence: Pascal Jean-Pierre, Ph.D., University of Rochester Medical Center, James P. Wilmot Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, New York 14642, USA. Telephone: 585-273-2545; Fax: 585-461-5601; e-mail: Pascal_Jean-Pierre{at}urmc.rochester.edu

Cancer-related fatigue (CRF) is a highly prevalent and debilitating symptom experienced by most cancer patients during, and often for considerable periods after, treatment. The recognition of the importance of CRF to patients' psychosocial and cognitive functioning, as well as to their quality of life, has driven the development of a wide range of assessment tools for screening and diagnosis of CRF. Over 20 different measures have been used to assess CRF from either a unidimensional or multi-dimensional perspective. Unidimensional measures are often single-question scales that generally focus on identifying the occurrence and severity of CRF, whereas multidimensional measures may also examine the effect of CRF across several domains of physical, socio-emotional, and cognitive functioning. This paper provides an overview and critique of measures commonly used to assess CRF. Single-question assessment is the most commonly used and the most useful methodology. Strategies to facilitate reliable assessment of CRF are also discussed.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
 J Oncol PractHome page
S. C. Higgins, G. H. Montgomery, G. Raptis, and D. H. Bovbjerg
Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer
J. Oncol. Pract, March 1, 2008; 4(2): 59 - 63.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
G. R. Morrow
Cancer-Related Fatigue: Causes, Consequences, and Management
Oncologist, May 1, 2007; 12(suppl_1): 1 - 3.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2007 by AlphaMed Press.
Advertisement